nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP2E1—lung cancer	0.186	0.645	CbGaD
Nortriptyline—ALB—lung cancer	0.102	0.355	CbGaD
Nortriptyline—ORM1—Gefitinib—lung cancer	0.057	0.127	CbGbCtD
Nortriptyline—ORM1—Erlotinib—lung cancer	0.0337	0.0751	CbGbCtD
Nortriptyline—ALB—Gefitinib—lung cancer	0.024	0.0535	CbGbCtD
Nortriptyline—CYP3A5—Gefitinib—lung cancer	0.0193	0.043	CbGbCtD
Nortriptyline—CYP3A5—Teniposide—lung cancer	0.0187	0.0417	CbGbCtD
Nortriptyline—CYP2C19—Gefitinib—lung cancer	0.0155	0.0347	CbGbCtD
Nortriptyline—CYP2C19—Teniposide—lung cancer	0.0151	0.0336	CbGbCtD
Nortriptyline—ALB—Erlotinib—lung cancer	0.0142	0.0316	CbGbCtD
Nortriptyline—PTGS1—Etoposide—lung cancer	0.0137	0.0306	CbGbCtD
Nortriptyline—CYP2C9—Gefitinib—lung cancer	0.0129	0.0288	CbGbCtD
Nortriptyline—ALB—Irinotecan—lung cancer	0.0128	0.0285	CbGbCtD
Nortriptyline—CYP2C9—Teniposide—lung cancer	0.0125	0.0279	CbGbCtD
Nortriptyline—CYP2D6—Gefitinib—lung cancer	0.0118	0.0263	CbGbCtD
Nortriptyline—CYP3A5—Crizotinib—lung cancer	0.0118	0.0263	CbGbCtD
Nortriptyline—CYP3A5—Erlotinib—lung cancer	0.0114	0.0254	CbGbCtD
Nortriptyline—CYP2E1—Etoposide—lung cancer	0.0106	0.0236	CbGbCtD
Nortriptyline—CYP3A5—Paclitaxel—lung cancer	0.0104	0.0233	CbGbCtD
Nortriptyline—CYP3A5—Irinotecan—lung cancer	0.0103	0.0229	CbGbCtD
Nortriptyline—CYP2D6—Vinorelbine—lung cancer	0.0091	0.0203	CbGbCtD
Nortriptyline—CYP1A2—Erlotinib—lung cancer	0.00848	0.0189	CbGbCtD
Nortriptyline—CYP3A5—Etoposide—lung cancer	0.00824	0.0184	CbGbCtD
Nortriptyline—CYP3A4—Topotecan—lung cancer	0.00822	0.0183	CbGbCtD
Nortriptyline—CYP3A5—Docetaxel—lung cancer	0.00754	0.0168	CbGbCtD
Nortriptyline—CYP3A4—Gefitinib—lung cancer	0.00752	0.0168	CbGbCtD
Nortriptyline—CYP3A4—Teniposide—lung cancer	0.00729	0.0162	CbGbCtD
Nortriptyline—CYP2C9—Paclitaxel—lung cancer	0.007	0.0156	CbGbCtD
Nortriptyline—CYP2D6—Erlotinib—lung cancer	0.00699	0.0156	CbGbCtD
Nortriptyline—ALB—Methotrexate—lung cancer	0.00678	0.0151	CbGbCtD
Nortriptyline—CYP1A2—Etoposide—lung cancer	0.00613	0.0137	CbGbCtD
Nortriptyline—CYP3A4—Vinorelbine—lung cancer	0.00579	0.0129	CbGbCtD
Nortriptyline—CYP2C9—Cisplatin—lung cancer	0.00563	0.0125	CbGbCtD
Nortriptyline—CYP2D6—Vinblastine—lung cancer	0.00561	0.0125	CbGbCtD
Nortriptyline—CYP3A4—Crizotinib—lung cancer	0.00461	0.0103	CbGbCtD
Nortriptyline—CYP3A4—Erlotinib—lung cancer	0.00444	0.00991	CbGbCtD
Nortriptyline—HTR2A—phrenic nerve—lung cancer	0.00429	0.251	CbGeAlD
Nortriptyline—CYP3A4—Paclitaxel—lung cancer	0.00407	0.00907	CbGbCtD
Nortriptyline—CYP3A4—Irinotecan—lung cancer	0.00401	0.00895	CbGbCtD
Nortriptyline—CYP3A4—Vinblastine—lung cancer	0.00357	0.00795	CbGbCtD
Nortriptyline—CYP2D6—Doxorubicin—lung cancer	0.00345	0.00769	CbGbCtD
Nortriptyline—CYP3A4—Etoposide—lung cancer	0.00321	0.00717	CbGbCtD
Nortriptyline—CYP3A4—Docetaxel—lung cancer	0.00294	0.00656	CbGbCtD
Nortriptyline—CYP3A4—Doxorubicin—lung cancer	0.00219	0.00489	CbGbCtD
Nortriptyline—HTR2A—pulmonary artery—lung cancer	0.00156	0.091	CbGeAlD
Nortriptyline—ALB—mammary gland—lung cancer	0.000764	0.0447	CbGeAlD
Nortriptyline—CHRM5—epithelium—lung cancer	0.000659	0.0385	CbGeAlD
Nortriptyline—ADRA1D—epithelium—lung cancer	0.000589	0.0344	CbGeAlD
Nortriptyline—SLC6A4—respiratory system—lung cancer	0.000495	0.0289	CbGeAlD
Nortriptyline—CYP2C9—mammary gland—lung cancer	0.000477	0.0279	CbGeAlD
Nortriptyline—SLC6A2—respiratory system—lung cancer	0.000436	0.0255	CbGeAlD
Nortriptyline—DRD2—respiratory system—lung cancer	0.000397	0.0232	CbGeAlD
Nortriptyline—CHRM1—trachea—lung cancer	0.000364	0.0213	CbGeAlD
Nortriptyline—ORM1—bone marrow—lung cancer	0.00034	0.0199	CbGeAlD
Nortriptyline—ADRA1A—epithelium—lung cancer	0.000338	0.0198	CbGeAlD
Nortriptyline—CYP1A2—respiratory system—lung cancer	0.000335	0.0196	CbGeAlD
Nortriptyline—CYP3A5—respiratory system—lung cancer	0.000323	0.0189	CbGeAlD
Nortriptyline—HRH1—respiratory system—lung cancer	0.000313	0.0183	CbGeAlD
Nortriptyline—ORM1—lung—lung cancer	0.000308	0.018	CbGeAlD
Nortriptyline—CYP2E1—respiratory system—lung cancer	0.000301	0.0176	CbGeAlD
Nortriptyline—PTGS1—respiratory system—lung cancer	0.00029	0.017	CbGeAlD
Nortriptyline—SLC6A4—lung—lung cancer	0.000263	0.0154	CbGeAlD
Nortriptyline—HRH1—epithelium—lung cancer	0.000262	0.0153	CbGeAlD
Nortriptyline—HTR2A—respiratory system—lung cancer	0.000262	0.0153	CbGeAlD
Nortriptyline—CHRM1—lung—lung cancer	0.000262	0.0153	CbGeAlD
Nortriptyline—PTGS1—epithelium—lung cancer	0.000242	0.0142	CbGeAlD
Nortriptyline—Clomipramine—GSTP1—lung cancer	0.000242	0.145	CrCbGaD
Nortriptyline—HRH1—trachea—lung cancer	0.000232	0.0135	CbGeAlD
Nortriptyline—SLC6A2—lung—lung cancer	0.000231	0.0135	CbGeAlD
Nortriptyline—HTR2A—epithelium—lung cancer	0.000219	0.0128	CbGeAlD
Nortriptyline—PTGS1—trachea—lung cancer	0.000214	0.0125	CbGeAlD
Nortriptyline—ORM1—lymph node—lung cancer	0.000211	0.0123	CbGeAlD
Nortriptyline—DRD2—lung—lung cancer	0.000211	0.0123	CbGeAlD
Nortriptyline—PTGS1—cardiac atrium—lung cancer	0.000201	0.0118	CbGeAlD
Nortriptyline—HTR2A—trachea—lung cancer	0.000193	0.0113	CbGeAlD
Nortriptyline—ALB—lymph node—lung cancer	0.000185	0.0108	CbGeAlD
Nortriptyline—CYP1A2—lung—lung cancer	0.000178	0.0104	CbGeAlD
Nortriptyline—CYP3A5—lung—lung cancer	0.000171	0.01	CbGeAlD
Nortriptyline—HRH1—lung—lung cancer	0.000166	0.00973	CbGeAlD
Nortriptyline—Protriptyline—ABCB1—lung cancer	0.000166	0.0995	CrCbGaD
Nortriptyline—CYP2E1—lung—lung cancer	0.00016	0.00935	CbGeAlD
Nortriptyline—SLC6A2—lymph node—lung cancer	0.000158	0.00925	CbGeAlD
Nortriptyline—PTGS1—lung—lung cancer	0.000154	0.00901	CbGeAlD
Nortriptyline—Desipramine—CYP2A6—lung cancer	0.000141	0.0844	CrCbGaD
Nortriptyline—HTR2A—lung—lung cancer	0.000139	0.00813	CbGeAlD
Nortriptyline—Epinastine—ABCB1—lung cancer	0.000123	0.0738	CrCbGaD
Nortriptyline—Oxcarbazepine—ALB—lung cancer	0.000119	0.0712	CrCbGaD
Nortriptyline—HRH1—lymph node—lung cancer	0.000114	0.00665	CbGeAlD
Nortriptyline—Alopecia—Docetaxel—lung cancer	0.000111	0.000766	CcSEcCtD
Nortriptyline—Pruritus—Vinorelbine—lung cancer	0.000111	0.000764	CcSEcCtD
Nortriptyline—Discomfort—Etoposide—lung cancer	0.000111	0.000763	CcSEcCtD
Nortriptyline—Constipation—Irinotecan—lung cancer	0.00011	0.000761	CcSEcCtD
Nortriptyline—Hypotension—Cisplatin—lung cancer	0.000109	0.000755	CcSEcCtD
Nortriptyline—Anxiety—Paclitaxel—lung cancer	0.000109	0.000755	CcSEcCtD
Nortriptyline—Decreased appetite—Gemcitabine—lung cancer	0.000109	0.000754	CcSEcCtD
Nortriptyline—Nausea—Topotecan—lung cancer	0.000109	0.00075	CcSEcCtD
Nortriptyline—Discomfort—Paclitaxel—lung cancer	0.000108	0.000748	CcSEcCtD
Nortriptyline—Fatigue—Gemcitabine—lung cancer	0.000108	0.000748	CcSEcCtD
Nortriptyline—Confusional state—Etoposide—lung cancer	0.000108	0.000747	CcSEcCtD
Nortriptyline—Constipation—Gemcitabine—lung cancer	0.000107	0.000742	CcSEcCtD
Nortriptyline—Nausea—Erlotinib—lung cancer	0.000107	0.000742	CcSEcCtD
Nortriptyline—Pancytopenia—Methotrexate—lung cancer	0.000107	0.000741	CcSEcCtD
Nortriptyline—Dry mouth—Paclitaxel—lung cancer	0.000107	0.000741	CcSEcCtD
Nortriptyline—Diarrhoea—Vinorelbine—lung cancer	0.000107	0.000739	CcSEcCtD
Nortriptyline—Dysgeusia—Docetaxel—lung cancer	0.000107	0.000739	CcSEcCtD
Nortriptyline—Ataxia—Doxorubicin—lung cancer	0.000106	0.000735	CcSEcCtD
Nortriptyline—Feeling abnormal—Irinotecan—lung cancer	0.000106	0.000734	CcSEcCtD
Nortriptyline—Confusional state—Paclitaxel—lung cancer	0.000106	0.000732	CcSEcCtD
Nortriptyline—Maprotiline—ABCB1—lung cancer	0.000106	0.0635	CrCbGaD
Nortriptyline—PTGS1—lymph node—lung cancer	0.000105	0.00616	CbGeAlD
Nortriptyline—Oedema—Paclitaxel—lung cancer	0.000105	0.000726	CcSEcCtD
Nortriptyline—Paraesthesia—Cisplatin—lung cancer	0.000105	0.000726	CcSEcCtD
Nortriptyline—Thrombocytopenia—Etoposide—lung cancer	0.000105	0.000725	CcSEcCtD
Nortriptyline—Tachycardia—Etoposide—lung cancer	0.000105	0.000723	CcSEcCtD
Nortriptyline—Erectile dysfunction—Methotrexate—lung cancer	0.000104	0.000719	CcSEcCtD
Nortriptyline—Hyperhidrosis—Etoposide—lung cancer	0.000104	0.000716	CcSEcCtD
Nortriptyline—Feeling abnormal—Gemcitabine—lung cancer	0.000103	0.000715	CcSEcCtD
Nortriptyline—Shock—Paclitaxel—lung cancer	0.000103	0.000714	CcSEcCtD
Nortriptyline—Dizziness—Vinorelbine—lung cancer	0.000103	0.000714	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Doxorubicin—lung cancer	0.000103	0.000714	CcSEcCtD
Nortriptyline—Thrombocytopenia—Paclitaxel—lung cancer	0.000103	0.000711	CcSEcCtD
Nortriptyline—Tachycardia—Paclitaxel—lung cancer	0.000103	0.000709	CcSEcCtD
Nortriptyline—Anorexia—Etoposide—lung cancer	0.000102	0.000706	CcSEcCtD
Nortriptyline—Body temperature increased—Irinotecan—lung cancer	0.000102	0.000704	CcSEcCtD
Nortriptyline—Abdominal pain—Irinotecan—lung cancer	0.000102	0.000704	CcSEcCtD
Nortriptyline—Decreased appetite—Cisplatin—lung cancer	0.000102	0.000703	CcSEcCtD
Nortriptyline—Hyperhidrosis—Paclitaxel—lung cancer	0.000102	0.000702	CcSEcCtD
Nortriptyline—Drowsiness—Methotrexate—lung cancer	0.000101	0.000696	CcSEcCtD
Nortriptyline—Anorexia—Paclitaxel—lung cancer	0.0001	0.000692	CcSEcCtD
Nortriptyline—Hypotension—Etoposide—lung cancer	0.0001	0.000692	CcSEcCtD
Nortriptyline—Desipramine—CYP2E1—lung cancer	9.98e-05	0.0599	CrCbGaD
Nortriptyline—Vomiting—Vinorelbine—lung cancer	9.94e-05	0.000686	CcSEcCtD
Nortriptyline—Body temperature increased—Gemcitabine—lung cancer	9.93e-05	0.000686	CcSEcCtD
Nortriptyline—Rash—Vinorelbine—lung cancer	9.85e-05	0.000681	CcSEcCtD
Nortriptyline—Dermatitis—Vinorelbine—lung cancer	9.85e-05	0.00068	CcSEcCtD
Nortriptyline—Hypotension—Paclitaxel—lung cancer	9.82e-05	0.000679	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—lung cancer	9.82e-05	0.000678	CcSEcCtD
Nortriptyline—Headache—Vinorelbine—lung cancer	9.79e-05	0.000676	CcSEcCtD
Nortriptyline—Syncope—Docetaxel—lung cancer	9.79e-05	0.000676	CcSEcCtD
Nortriptyline—Leukopenia—Docetaxel—lung cancer	9.77e-05	0.000675	CcSEcCtD
Nortriptyline—Eosinophilia—Doxorubicin—lung cancer	9.68e-05	0.000669	CcSEcCtD
Nortriptyline—Sweating—Methotrexate—lung cancer	9.65e-05	0.000667	CcSEcCtD
Nortriptyline—Palpitations—Docetaxel—lung cancer	9.65e-05	0.000666	CcSEcCtD
Nortriptyline—Feeling abnormal—Cisplatin—lung cancer	9.64e-05	0.000666	CcSEcCtD
Nortriptyline—Paraesthesia—Etoposide—lung cancer	9.63e-05	0.000665	CcSEcCtD
Nortriptyline—Loss of consciousness—Docetaxel—lung cancer	9.6e-05	0.000663	CcSEcCtD
Nortriptyline—Somnolence—Etoposide—lung cancer	9.53e-05	0.000658	CcSEcCtD
Nortriptyline—Insomnia—Paclitaxel—lung cancer	9.51e-05	0.000657	CcSEcCtD
Nortriptyline—Hypersensitivity—Irinotecan—lung cancer	9.5e-05	0.000656	CcSEcCtD
Nortriptyline—Convulsion—Docetaxel—lung cancer	9.46e-05	0.000653	CcSEcCtD
Nortriptyline—Paraesthesia—Paclitaxel—lung cancer	9.44e-05	0.000652	CcSEcCtD
Nortriptyline—Hypertension—Docetaxel—lung cancer	9.43e-05	0.000651	CcSEcCtD
Nortriptyline—Agranulocytosis—Methotrexate—lung cancer	9.4e-05	0.000649	CcSEcCtD
Nortriptyline—Somnolence—Paclitaxel—lung cancer	9.35e-05	0.000646	CcSEcCtD
Nortriptyline—Decreased appetite—Etoposide—lung cancer	9.32e-05	0.000644	CcSEcCtD
Nortriptyline—Pancytopenia—Doxorubicin—lung cancer	9.29e-05	0.000642	CcSEcCtD
Nortriptyline—Nausea—Vinorelbine—lung cancer	9.28e-05	0.000641	CcSEcCtD
Nortriptyline—Dyspepsia—Paclitaxel—lung cancer	9.25e-05	0.000639	CcSEcCtD
Nortriptyline—Body temperature increased—Cisplatin—lung cancer	9.25e-05	0.000639	CcSEcCtD
Nortriptyline—Asthenia—Irinotecan—lung cancer	9.25e-05	0.000639	CcSEcCtD
Nortriptyline—Fatigue—Etoposide—lung cancer	9.24e-05	0.000639	CcSEcCtD
Nortriptyline—Constipation—Etoposide—lung cancer	9.17e-05	0.000633	CcSEcCtD
Nortriptyline—Decreased appetite—Paclitaxel—lung cancer	9.14e-05	0.000631	CcSEcCtD
Nortriptyline—Dry mouth—Docetaxel—lung cancer	9.09e-05	0.000628	CcSEcCtD
Nortriptyline—Fatigue—Paclitaxel—lung cancer	9.06e-05	0.000626	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—lung cancer	9.04e-05	0.000624	CcSEcCtD
Nortriptyline—Pollakiuria—Doxorubicin—lung cancer	9.03e-05	0.000624	CcSEcCtD
Nortriptyline—Asthenia—Gemcitabine—lung cancer	9.01e-05	0.000622	CcSEcCtD
Nortriptyline—Constipation—Paclitaxel—lung cancer	8.99e-05	0.000621	CcSEcCtD
Nortriptyline—Confusional state—Docetaxel—lung cancer	8.98e-05	0.000621	CcSEcCtD
Nortriptyline—Oedema—Docetaxel—lung cancer	8.91e-05	0.000616	CcSEcCtD
Nortriptyline—Weight increased—Doxorubicin—lung cancer	8.9e-05	0.000615	CcSEcCtD
Nortriptyline—Pruritus—Gemcitabine—lung cancer	8.88e-05	0.000614	CcSEcCtD
Nortriptyline—Weight decreased—Doxorubicin—lung cancer	8.85e-05	0.000611	CcSEcCtD
Nortriptyline—Feeling abnormal—Etoposide—lung cancer	8.84e-05	0.00061	CcSEcCtD
Nortriptyline—Diarrhoea—Irinotecan—lung cancer	8.82e-05	0.000609	CcSEcCtD
Nortriptyline—Shock—Docetaxel—lung cancer	8.77e-05	0.000606	CcSEcCtD
Nortriptyline—Thrombocytopenia—Docetaxel—lung cancer	8.72e-05	0.000603	CcSEcCtD
Nortriptyline—Drowsiness—Doxorubicin—lung cancer	8.72e-05	0.000602	CcSEcCtD
Nortriptyline—Tachycardia—Docetaxel—lung cancer	8.7e-05	0.000601	CcSEcCtD
Nortriptyline—Feeling abnormal—Paclitaxel—lung cancer	8.66e-05	0.000598	CcSEcCtD
Nortriptyline—Hypersensitivity—Cisplatin—lung cancer	8.62e-05	0.000596	CcSEcCtD
Nortriptyline—Diarrhoea—Gemcitabine—lung cancer	8.59e-05	0.000593	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Doxorubicin—lung cancer	8.55e-05	0.00059	CcSEcCtD
Nortriptyline—Dizziness—Irinotecan—lung cancer	8.52e-05	0.000589	CcSEcCtD
Nortriptyline—Urticaria—Etoposide—lung cancer	8.52e-05	0.000588	CcSEcCtD
Nortriptyline—Jaundice—Doxorubicin—lung cancer	8.5e-05	0.000587	CcSEcCtD
Nortriptyline—Stomatitis—Doxorubicin—lung cancer	8.5e-05	0.000587	CcSEcCtD
Nortriptyline—Anorexia—Docetaxel—lung cancer	8.49e-05	0.000587	CcSEcCtD
Nortriptyline—Abdominal pain—Etoposide—lung cancer	8.48e-05	0.000585	CcSEcCtD
Nortriptyline—Body temperature increased—Etoposide—lung cancer	8.48e-05	0.000585	CcSEcCtD
Nortriptyline—Imipramine—CYP2E1—lung cancer	8.46e-05	0.0508	CrCbGaD
Nortriptyline—Eye disorder—Methotrexate—lung cancer	8.45e-05	0.000584	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—lung cancer	8.43e-05	0.000582	CcSEcCtD
Nortriptyline—Amitriptyline—CYP2E1—lung cancer	8.41e-05	0.0505	CrCbGaD
Nortriptyline—Asthenia—Cisplatin—lung cancer	8.4e-05	0.00058	CcSEcCtD
Nortriptyline—Sweating—Doxorubicin—lung cancer	8.36e-05	0.000577	CcSEcCtD
Nortriptyline—Urticaria—Paclitaxel—lung cancer	8.35e-05	0.000577	CcSEcCtD
Nortriptyline—Hypotension—Docetaxel—lung cancer	8.33e-05	0.000575	CcSEcCtD
Nortriptyline—Body temperature increased—Paclitaxel—lung cancer	8.31e-05	0.000574	CcSEcCtD
Nortriptyline—Abdominal pain—Paclitaxel—lung cancer	8.31e-05	0.000574	CcSEcCtD
Nortriptyline—Vomiting—Irinotecan—lung cancer	8.2e-05	0.000566	CcSEcCtD
Nortriptyline—Agranulocytosis—Doxorubicin—lung cancer	8.14e-05	0.000562	CcSEcCtD
Nortriptyline—Rash—Irinotecan—lung cancer	8.13e-05	0.000561	CcSEcCtD
Nortriptyline—Dermatitis—Irinotecan—lung cancer	8.12e-05	0.000561	CcSEcCtD
Nortriptyline—Headache—Irinotecan—lung cancer	8.08e-05	0.000558	CcSEcCtD
Nortriptyline—Insomnia—Docetaxel—lung cancer	8.06e-05	0.000557	CcSEcCtD
Nortriptyline—Diarrhoea—Cisplatin—lung cancer	8.01e-05	0.000553	CcSEcCtD
Nortriptyline—Paraesthesia—Docetaxel—lung cancer	8e-05	0.000553	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—lung cancer	7.99e-05	0.000552	CcSEcCtD
Nortriptyline—Vomiting—Gemcitabine—lung cancer	7.98e-05	0.000551	CcSEcCtD
Nortriptyline—Somnolence—Docetaxel—lung cancer	7.92e-05	0.000547	CcSEcCtD
Nortriptyline—Rash—Gemcitabine—lung cancer	7.92e-05	0.000547	CcSEcCtD
Nortriptyline—Dermatitis—Gemcitabine—lung cancer	7.91e-05	0.000546	CcSEcCtD
Nortriptyline—Hypersensitivity—Etoposide—lung cancer	7.9e-05	0.000546	CcSEcCtD
Nortriptyline—Headache—Gemcitabine—lung cancer	7.87e-05	0.000543	CcSEcCtD
Nortriptyline—Dyspepsia—Docetaxel—lung cancer	7.84e-05	0.000542	CcSEcCtD
Nortriptyline—Hepatitis—Doxorubicin—lung cancer	7.83e-05	0.000541	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—lung cancer	7.79e-05	0.000538	CcSEcCtD
Nortriptyline—Decreased appetite—Docetaxel—lung cancer	7.75e-05	0.000535	CcSEcCtD
Nortriptyline—Hypersensitivity—Paclitaxel—lung cancer	7.75e-05	0.000535	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—lung cancer	7.71e-05	0.000533	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—lung cancer	7.71e-05	0.000532	CcSEcCtD
Nortriptyline—Asthenia—Etoposide—lung cancer	7.69e-05	0.000531	CcSEcCtD
Nortriptyline—Fatigue—Docetaxel—lung cancer	7.68e-05	0.000531	CcSEcCtD
Nortriptyline—Nausea—Irinotecan—lung cancer	7.66e-05	0.000529	CcSEcCtD
Nortriptyline—Constipation—Docetaxel—lung cancer	7.62e-05	0.000526	CcSEcCtD
Nortriptyline—Pruritus—Etoposide—lung cancer	7.59e-05	0.000524	CcSEcCtD
Nortriptyline—Asthenia—Paclitaxel—lung cancer	7.54e-05	0.000521	CcSEcCtD
Nortriptyline—Nausea—Gemcitabine—lung cancer	7.46e-05	0.000515	CcSEcCtD
Nortriptyline—Vomiting—Cisplatin—lung cancer	7.44e-05	0.000514	CcSEcCtD
Nortriptyline—Pruritus—Paclitaxel—lung cancer	7.44e-05	0.000514	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—lung cancer	7.42e-05	0.000512	CcSEcCtD
Nortriptyline—Rash—Cisplatin—lung cancer	7.38e-05	0.00051	CcSEcCtD
Nortriptyline—Dermatitis—Cisplatin—lung cancer	7.37e-05	0.000509	CcSEcCtD
Nortriptyline—Feeling abnormal—Docetaxel—lung cancer	7.34e-05	0.000507	CcSEcCtD
Nortriptyline—Diarrhoea—Etoposide—lung cancer	7.34e-05	0.000507	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—lung cancer	7.32e-05	0.000505	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—lung cancer	7.3e-05	0.000504	CcSEcCtD
Nortriptyline—Tinnitus—Doxorubicin—lung cancer	7.3e-05	0.000504	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—lung cancer	7.26e-05	0.000502	CcSEcCtD
Nortriptyline—Diarrhoea—Paclitaxel—lung cancer	7.19e-05	0.000497	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—lung cancer	7.1e-05	0.00049	CcSEcCtD
Nortriptyline—Dizziness—Etoposide—lung cancer	7.09e-05	0.00049	CcSEcCtD
Nortriptyline—Body temperature increased—Docetaxel—lung cancer	7.04e-05	0.000487	CcSEcCtD
Nortriptyline—Abdominal pain—Docetaxel—lung cancer	7.04e-05	0.000487	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—lung cancer	7.04e-05	0.000487	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—lung cancer	6.99e-05	0.000483	CcSEcCtD
Nortriptyline—Dizziness—Paclitaxel—lung cancer	6.95e-05	0.00048	CcSEcCtD
Nortriptyline—Nausea—Cisplatin—lung cancer	6.95e-05	0.00048	CcSEcCtD
Nortriptyline—Alopecia—Doxorubicin—lung cancer	6.92e-05	0.000478	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—lung cancer	6.82e-05	0.000471	CcSEcCtD
Nortriptyline—Vomiting—Etoposide—lung cancer	6.82e-05	0.000471	CcSEcCtD
Nortriptyline—Clomipramine—ALB—lung cancer	6.81e-05	0.0409	CrCbGaD
Nortriptyline—Rash—Etoposide—lung cancer	6.76e-05	0.000467	CcSEcCtD
Nortriptyline—Dermatitis—Etoposide—lung cancer	6.75e-05	0.000467	CcSEcCtD
Nortriptyline—Headache—Etoposide—lung cancer	6.72e-05	0.000464	CcSEcCtD
Nortriptyline—Tension—Doxorubicin—lung cancer	6.69e-05	0.000462	CcSEcCtD
Nortriptyline—Vomiting—Paclitaxel—lung cancer	6.68e-05	0.000462	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—lung cancer	6.67e-05	0.000461	CcSEcCtD
Nortriptyline—Rash—Paclitaxel—lung cancer	6.63e-05	0.000458	CcSEcCtD
Nortriptyline—Dermatitis—Paclitaxel—lung cancer	6.62e-05	0.000457	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—lung cancer	6.62e-05	0.000457	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—lung cancer	6.62e-05	0.000457	CcSEcCtD
Nortriptyline—Headache—Paclitaxel—lung cancer	6.59e-05	0.000455	CcSEcCtD
Nortriptyline—Hypersensitivity—Docetaxel—lung cancer	6.57e-05	0.000453	CcSEcCtD
Nortriptyline—Clomipramine—ABCB1—lung cancer	6.5e-05	0.039	CrCbGaD
Nortriptyline—Confusional state—Methotrexate—lung cancer	6.48e-05	0.000447	CcSEcCtD
Nortriptyline—Chlorprothixene—ABCB1—lung cancer	6.47e-05	0.0389	CrCbGaD
Nortriptyline—Vision blurred—Doxorubicin—lung cancer	6.42e-05	0.000444	CcSEcCtD
Nortriptyline—Asthenia—Docetaxel—lung cancer	6.39e-05	0.000442	CcSEcCtD
Nortriptyline—Nausea—Etoposide—lung cancer	6.37e-05	0.00044	CcSEcCtD
Nortriptyline—Ill-defined disorder—Doxorubicin—lung cancer	6.32e-05	0.000437	CcSEcCtD
Nortriptyline—Pruritus—Docetaxel—lung cancer	6.3e-05	0.000435	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—lung cancer	6.29e-05	0.000434	CcSEcCtD
Nortriptyline—Agitation—Doxorubicin—lung cancer	6.26e-05	0.000433	CcSEcCtD
Nortriptyline—Nausea—Paclitaxel—lung cancer	6.24e-05	0.000431	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—lung cancer	6.21e-05	0.000429	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—lung cancer	6.14e-05	0.000424	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—lung cancer	6.12e-05	0.000423	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—lung cancer	6.11e-05	0.000422	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—lung cancer	6.1e-05	0.000421	CcSEcCtD
Nortriptyline—Diarrhoea—Docetaxel—lung cancer	6.1e-05	0.000421	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—lung cancer	6.02e-05	0.000416	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—lung cancer	6e-05	0.000415	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—lung cancer	5.99e-05	0.000414	CcSEcCtD
Nortriptyline—Trimipramine—ABCB1—lung cancer	5.98e-05	0.0359	CrCbGaD
Nortriptyline—Convulsion—Doxorubicin—lung cancer	5.9e-05	0.000408	CcSEcCtD
Nortriptyline—Dizziness—Docetaxel—lung cancer	5.89e-05	0.000407	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—lung cancer	5.88e-05	0.000406	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—lung cancer	5.81e-05	0.000401	CcSEcCtD
Nortriptyline—Anxiety—Doxorubicin—lung cancer	5.78e-05	0.000399	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—lung cancer	5.77e-05	0.000398	CcSEcCtD
Nortriptyline—Discomfort—Doxorubicin—lung cancer	5.73e-05	0.000396	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—lung cancer	5.71e-05	0.000394	CcSEcCtD
Nortriptyline—Doxepin—ABCB1—lung cancer	5.7e-05	0.0342	CrCbGaD
Nortriptyline—Dry mouth—Doxorubicin—lung cancer	5.67e-05	0.000392	CcSEcCtD
Nortriptyline—Vomiting—Docetaxel—lung cancer	5.67e-05	0.000391	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—lung cancer	5.65e-05	0.000391	CcSEcCtD
Nortriptyline—Rash—Docetaxel—lung cancer	5.62e-05	0.000388	CcSEcCtD
Nortriptyline—Dermatitis—Docetaxel—lung cancer	5.61e-05	0.000388	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—lung cancer	5.61e-05	0.000387	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—lung cancer	5.58e-05	0.000386	CcSEcCtD
Nortriptyline—Headache—Docetaxel—lung cancer	5.58e-05	0.000386	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—lung cancer	5.56e-05	0.000384	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—lung cancer	5.54e-05	0.000382	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—lung cancer	5.47e-05	0.000378	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—lung cancer	5.44e-05	0.000376	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—lung cancer	5.43e-05	0.000375	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—lung cancer	5.38e-05	0.000371	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—lung cancer	5.3e-05	0.000366	CcSEcCtD
Nortriptyline—Nausea—Docetaxel—lung cancer	5.29e-05	0.000366	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—lung cancer	5.29e-05	0.000366	CcSEcCtD
Nortriptyline—Desipramine—ABCB1—lung cancer	5.23e-05	0.0314	CrCbGaD
Nortriptyline—Hypotension—Doxorubicin—lung cancer	5.2e-05	0.000359	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—lung cancer	5.1e-05	0.000352	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—lung cancer	5.08e-05	0.000351	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—lung cancer	5.08e-05	0.000351	CcSEcCtD
Nortriptyline—Insomnia—Doxorubicin—lung cancer	5.03e-05	0.000347	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—lung cancer	4.99e-05	0.000345	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—lung cancer	4.94e-05	0.000342	CcSEcCtD
Nortriptyline—Dyspepsia—Doxorubicin—lung cancer	4.9e-05	0.000338	CcSEcCtD
Nortriptyline—Decreased appetite—Doxorubicin—lung cancer	4.83e-05	0.000334	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—lung cancer	4.79e-05	0.000331	CcSEcCtD
Nortriptyline—Constipation—Doxorubicin—lung cancer	4.76e-05	0.000329	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—lung cancer	4.73e-05	0.000327	CcSEcCtD
Nortriptyline—Amitriptyline—ALB—lung cancer	4.62e-05	0.0277	CrCbGaD
Nortriptyline—Asthenia—Methotrexate—lung cancer	4.61e-05	0.000318	CcSEcCtD
Nortriptyline—Feeling abnormal—Doxorubicin—lung cancer	4.58e-05	0.000317	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—lung cancer	4.54e-05	0.000314	CcSEcCtD
Nortriptyline—Imipramine—ABCB1—lung cancer	4.44e-05	0.0266	CrCbGaD
Nortriptyline—Urticaria—Doxorubicin—lung cancer	4.42e-05	0.000305	CcSEcCtD
Nortriptyline—Amitriptyline—ABCB1—lung cancer	4.41e-05	0.0265	CrCbGaD
Nortriptyline—Abdominal pain—Doxorubicin—lung cancer	4.4e-05	0.000304	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—lung cancer	4.4e-05	0.000304	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—lung cancer	4.39e-05	0.000304	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—lung cancer	4.25e-05	0.000293	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—lung cancer	4.1e-05	0.000283	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—lung cancer	4.08e-05	0.000282	CcSEcCtD
Nortriptyline—Rash—Methotrexate—lung cancer	4.05e-05	0.00028	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—lung cancer	4.05e-05	0.000279	CcSEcCtD
Nortriptyline—Headache—Methotrexate—lung cancer	4.02e-05	0.000278	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—lung cancer	3.99e-05	0.000276	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—lung cancer	3.93e-05	0.000272	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—lung cancer	3.81e-05	0.000264	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—lung cancer	3.81e-05	0.000263	CcSEcCtD
Nortriptyline—Dizziness—Doxorubicin—lung cancer	3.68e-05	0.000254	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—lung cancer	3.54e-05	0.000244	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—lung cancer	3.51e-05	0.000242	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—lung cancer	3.5e-05	0.000242	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—lung cancer	3.48e-05	0.000241	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—lung cancer	3.3e-05	0.000228	CcSEcCtD
Nortriptyline—DRD2—Signaling Pathways—CDKN1A—lung cancer	2.17e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—lung cancer	2.16e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—lung cancer	2.16e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—JUN—lung cancer	2.16e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—lung cancer	2.16e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—JUN—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—lung cancer	2.15e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—lung cancer	2.15e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—lung cancer	2.14e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—lung cancer	2.14e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—lung cancer	2.13e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1A—lung cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—lung cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1A—lung cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—lung cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—lung cancer	2.12e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAT—lung cancer	2.12e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—lung cancer	2.12e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—lung cancer	2.12e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—lung cancer	2.12e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1A—lung cancer	2.12e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CA—lung cancer	2.12e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—lung cancer	2.12e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—lung cancer	2.12e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1A—lung cancer	2.11e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CB—lung cancer	2.11e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOA1—lung cancer	2.11e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CREBBP—lung cancer	2.11e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—lung cancer	2.11e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—lung cancer	2.11e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK3—lung cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—lung cancer	2.1e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—lung cancer	2.1e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CREBBP—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1A—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK3—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—lung cancer	2.09e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—lung cancer	2.09e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	2.09e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—lung cancer	2.08e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—lung cancer	2.08e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—lung cancer	2.07e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—lung cancer	2.07e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCB1—lung cancer	2.07e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—lung cancer	2.06e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EP300—lung cancer	2.06e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—lung cancer	2.06e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—lung cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—lung cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—lung cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—lung cancer	2.04e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—lung cancer	2.04e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TYMS—lung cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EP300—lung cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—EP300—lung cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EP300—lung cancer	2.02e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.02e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—EP300—lung cancer	2.02e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EP300—lung cancer	2.02e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EP300—lung cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CA—lung cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—lung cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SRC—lung cancer	2e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CD—lung cancer	2e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—lung cancer	2e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	1.99e-06	2e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EP300—lung cancer	1.99e-06	2e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—lung cancer	1.99e-06	2e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EP300—lung cancer	1.99e-06	2e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CD—lung cancer	1.98e-06	2e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—lung cancer	1.98e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SRC—lung cancer	1.97e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SRC—lung cancer	1.97e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SRC—lung cancer	1.96e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—lung cancer	1.96e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—lung cancer	1.96e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—lung cancer	1.96e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SRC—lung cancer	1.96e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—lung cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—lung cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SRC—lung cancer	1.94e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—lung cancer	1.93e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SRC—lung cancer	1.93e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—lung cancer	1.93e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—lung cancer	1.93e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—lung cancer	1.93e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.92e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—lung cancer	1.92e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—lung cancer	1.92e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.91e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.91e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.9e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—lung cancer	1.9e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP1A1—lung cancer	1.9e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—lung cancer	1.9e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—lung cancer	1.9e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CB—lung cancer	1.9e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KRAS—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ERCC2—lung cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—lung cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KRAS—lung cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—lung cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—lung cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—lung cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—lung cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK3—lung cancer	1.85e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.84e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—lung cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—lung cancer	1.83e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.82e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK3—lung cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—lung cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—lung cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CREBBP—lung cancer	1.79e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.78e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CA—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—lung cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—lung cancer	1.76e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—lung cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—lung cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—lung cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—lung cancer	1.75e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CB—lung cancer	1.74e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—EP300—lung cancer	1.74e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.74e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—lung cancer	1.74e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CB—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—lung cancer	1.72e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—lung cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—lung cancer	1.71e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—lung cancer	1.71e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—lung cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CD—lung cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—lung cancer	1.68e-06	1.69e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—lung cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—lung cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KRAS—lung cancer	1.66e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—lung cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—lung cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KRAS—lung cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOA1—lung cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KRAS—lung cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KRAS—lung cancer	1.62e-06	1.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KRAS—lung cancer	1.62e-06	1.63e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—lung cancer	1.61e-06	1.62e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KRAS—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—EP300—lung cancer	1.56e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—lung cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—lung cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—lung cancer	1.51e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CA—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CA—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—lung cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—lung cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CB—lung cancer	1.48e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—lung cancer	1.48e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—lung cancer	1.46e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—lung cancer	1.46e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—lung cancer	1.44e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—lung cancer	1.44e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—EP300—lung cancer	1.44e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—EP300—lung cancer	1.43e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—lung cancer	1.43e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—lung cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—lung cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—lung cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—lung cancer	1.39e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—lung cancer	1.38e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CREBBP—lung cancer	1.38e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—lung cancer	1.38e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—lung cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—lung cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—lung cancer	1.33e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—lung cancer	1.33e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—lung cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—lung cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CD—lung cancer	1.31e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—lung cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—lung cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—lung cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CA—lung cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—lung cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—lung cancer	1.25e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—lung cancer	1.23e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—lung cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—lung cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—lung cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—lung cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—EP300—lung cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—lung cancer	1.22e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—lung cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CA—lung cancer	1.16e-06	1.16e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CB—lung cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—lung cancer	1.13e-06	1.14e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CA—lung cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CA—lung cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—lung cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—lung cancer	9.86e-07	9.92e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—lung cancer	9.45e-07	9.51e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—EP300—lung cancer	9.4e-07	9.46e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CA—lung cancer	9.01e-07	9.07e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—lung cancer	8.69e-07	8.74e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—lung cancer	8.61e-07	8.67e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—lung cancer	7.36e-07	7.41e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CA—lung cancer	6.95e-07	7e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—lung cancer	5.68e-07	5.72e-06	CbGpPWpGaD
